A comparative safety analysis for durvalumab in patients with locally advanced, unresectable NSCLC: PACIFIC versus pooled durvalumab monotherapy studies Meeting Abstract


Authors: Antonia, S. J.; Hellmann, M. D.; Dennis, P. A.; Melillo, G.; Abdullah, S. E.; Lloyd, A.; Rizvi, N. A.
Abstract Title: A comparative safety analysis for durvalumab in patients with locally advanced, unresectable NSCLC: PACIFIC versus pooled durvalumab monotherapy studies
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 451s
Language: English
ACCESSION: WOS:000442916003152
DOI: 10.1200/JCO.2018.36.15_suppl.8556
PROVIDER: wos
Notes: Meeting Abstract: 8556 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    411 Hellmann